Tenax Therapeutics

Tenax Therapeutics is focused on developing and commercializing pharmaceutical products that improve outcomes for patients who require treatment for various critical care conditions.

Our development portfolio includes novel product candidates that have the potential to address various critical care conditions with high unmet medical need.

Type
Public
HQ
Morrisville, US
Size (employees)
10 (est)
Tenax Therapeutics is headquartered in Morrisville, US

Tenax Therapeutics Office Locations

Tenax Therapeutics has an office in Morrisville
Morrisville, US (HQ)
490 1 Copley Pkwy

Tenax Therapeutics Metrics

Tenax Therapeutics Financial Metrics

Revenue growth (2015-16), %

(100%)

Net income (2016)

$10.1 m

Market capitalization (28-Apr-2017)

$14.9 m

Closing share price (28-Apr-2017)

$0.6

Cash (31-Dec-2016)

$10 m
Tenax Therapeutics's current market capitalization is $14.9 m.
Tenax Therapeutics's revenue was reported to be $0 in 2016
FY, 2014FY, 2015Y, 2016

Revenue

$158.9 k$49.3 k

Revenue growth, %

(69%)(100%)

Cost of goods sold

$129.8 k

Gross profit

$29.1 k

Gross profit Margin, %

18%

Operating expense total

$16.8 m$14.9 m$10.4 m

Interest expense

$2.2 m$49.1 k$1.5 k

Income tax expense

Net Income

($19.5 m)($14.1 m)$10.1 m
FY, 2014FY, 2015FY, 2016

Cash

$58.3 m$7.9 m$10 m

Accounts Receivable

$36.4 k$76.5 k$72.6 k

Inventories

Current Assets

$59 m$17.5 m$13.6 m

PP&E

$124.4 k$50.3 k$19.1 k

Goodwill

$11.3 m$11.3 m

Total Assets

$93.4 m$82.9 m$23.3 m

Accounts Payable

$411.1 k$1.2 m$727.6 k

Current Liabilities

$2.6 m$4.5 m$6.2 m

Additional Paid-in Capital

$219.5 m$221.1 m$221.8 m

Retained Earnings

($150.7 m)($204.7 m)

Total Equity

$82.9 m$70.4 m$17.1 m

Financial Leverage

1.1 x1.2 x1.4 x
FY, 2014FY, 2015FY, 2016

Net Income

($19.5 m)($14.1 m)($43.9 m)

Depreciation and Amortization

$150.5 k$148.1 k$31.2 k

Accounts Receivable

Inventories

$99.2 k

Accounts Payable

Cash From Operating Activities

($9.3 m)($9.7 m)($9 m)

Purchases of PP&E

($9.8 k)($4.2 k)($16.7 k)

Cash From Investing Activities

($147 k)($40.9 m)$4.8 m

Cash From Financing Activities

$66.9 m$280.6 k($100.2 k)

Interest Paid

$30.3 k$3.5 k$1.5 k

Income Taxes Paid

Tenax Therapeutics Market Value History

Tenax Therapeutics Company Life

You may also be interested in